PharVision Advisers’s Semrush SEMR Stock Holding History

PharVision Advisers’s Portfolio SEMR Stock Details SEMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-17,933	Closed	-$213K	–	489
2024 Q4	$213K	Buy	+17,933	New	+$241K	0.18%	275

Other funds holding SEMR

Greycroft New York $146M AUM 1.94% 1-Year Est. Return

RCP

RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return

SGA

Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CRCM

Cat Rock Capital Management Greenwich, Connecticut $644M AUM 1.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DAM

Dorsey Asset Management Chicago, Illinois $1.26B AUM 18.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PharVision Advisers's SEMR Position: Q1 2025 in Review

PharVision Advisers sold out of Semrush (SEMR) in Q1 2025, closing a stake of 17,933 shares — an estimated $213K sold.

PharVision Advisers first reported a position in SEMR in Q4 2024 and held it in 1 quarter. The position peaked at $213K in Q4 2024. 172 funds tracked by Wall St. Rank hold SEMR as of Q1 2025.

PharVision Advisers reported no remaining Semrush position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 17,933 Semrush shares in Q1 2025, an estimated $213K.
PharVision Advisers first reported a position in Semrush in Q4 2024 and held it in 1 quarter.
PharVision Advisers's Semrush position peaked at $213K in Q4 2024.
172 funds tracked by Wall St. Rank held Semrush as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.